✨ Medicines Distribution Consents




24 JANUARY 2008 NEW ZEALAND GAZETTE, No. 9

253

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of
the changed medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are
set out in the Schedule hereto:

Schedule

Product:
Alimta

Active Ingredient:
Pemetrexed sodium 713mg equivalent to pemetrexed free acid 500mg

Dosage Form:
Powder for infusion

New Zealand Sponsor:
Eli Lilly and Company (NZ) Limited

Manufacturer:
Lilly France SAS, Fegersheim, France

Product:
NovoMix 30 Flexpen

Active Ingredient:
Insulin aspart 100IU/mL

Dosage Form:
Suspension for injection

New Zealand Sponsor:
Novo Nordisk Pharmaceuticals Limited

Manufacturers:
Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark
Novo Nordisk Production S.A.S, Chartres Cedex, France

Product:
NovoMix 30 Penfill

Active Ingredient:
Insulin aspart 100IU/mL

Dosage Form:
Suspension for injection

New Zealand Sponsor:
Novo Nordisk Pharmaceuticals Limited

Manufacturers:
Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark
Novo Nordisk Production S.A.S, Chartres Cedex, France

Dated this 18th day of January 2008.

JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation
given by the Minister of Health on 6 July 2001).

go428

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of
the new medicines set out in the Schedule hereto:

Schedule

Product:
Cervarix

Active Ingredients:
Human Papillomavirus (HPV) 16 L1 Protein 20Β΅g
Human Papillomavirus (HPV) 18 L1 Protein 20Β΅g

Dosage Form:
Suspension for injection

New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited

Manufacturers:
GlaxoSmithKline Biologicals SA, Parc de la Noire Epine, Wavre, Belgium
GlaxoSmithKline Biologicals SA, Rixensart, Belgium

Product:
Emend IV

Active Ingredient:
Fosaprepitant dimeglumine 40mg/mL

Dosage Form:
Powder for injection

New Zealand Sponsor:
Merck Sharp & Dohme (New Zealand) Limited

Manufacturer:
DSM Pharmaceuticals Inc, Greenville, North Carolina, United States of America

Product:
Lamivudine

Active Ingredient:
Lamivudine 10mg/mL

Dosage Form:
Oral solution

New Zealand Sponsor:
REX Medical Limited

Manufacturer:
Cipla Limited, Salcette, Goa, India

Product:
Oxytrol

Active Ingredient:
Oxybutynin 36mg

Dosage Form:
Transdermal patch

New Zealand Sponsor:
Hospira NZ Limited

Manufacturer:
Watson Pharmaceuticals Inc., Salt Lake City, Utah, United States of America

Dated this 18th day of January 2008.\n
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation
given by the Minister of Health on 6 July 2001).

go429



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2008, No 9


Gazette.govt.nz PDF NZ Gazette 2008, No 9





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of Changed Medicines

πŸ₯ Health & Social Welfare
18 January 2008
Medicines Act 1981, Changed Medicines, Distribution, Alimta, NovoMix 30 Flexpen, NovoMix 30 Penfill
  • JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
18 January 2008
Medicines Act 1981, New Medicines, Distribution, Cervarix, Emend IV, Lamivudine, Oxytrol
  • JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate